ARENA PHARMACEUTICALS INC 4

4 · ARENA PHARMACEUTICALS INC · Filed Jan 17, 2014

Form 4

Period: 2014-01-17

DirectorChairman, President and CEO

Transactions

Sale
Common Stock
2014-01-17$7.81/sh−100,000$781,260→ 583,704 total
Exercise/Conversion
Common Stock
2014-01-17$6.00/sh+100,000$600,000→ 683,704 total
Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-17−100,000→ 0 total
Exercise: $6.00From: 2004-01-18Exp: 2014-01-18→ Common Stock (100,000 underlying)

Footnotes (4)

[F1]The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction.
[F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F3]This price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.67 and $7.92 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F4]The options were exercisable upon grant, but vested in four approximately equal annual installments beginning on January 18, 2005.

Documents

1 file